A Novel Biocompatible Nanoprobe Based on Lipoproteins for Breast Cancer Cell Imaging

  • سال انتشار: 1399
  • محل انتشار: مجله علوم نانو، دوره: 7، شماره: 1
  • کد COI اختصاصی: JR_NAMJ-7-1_009
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 622
دانلود فایل این مقاله

نویسندگان

Mehdi Mirzaei

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran|Iran Ministry of Health and Medical Education, Deputy Ministry for Education, Tehran, Iran

Mohammad Esmaeil Akbari

Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Mohammad Ali Mohagheghi

Cancer Institute Research Center, Tehran University of Medical Sciences, Tehran, Iran

Seyed Amir Mohsen Ziaee

Labbafinejad Medical Center, Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran

چکیده

Objective(s): Contrast-enhanced magnetic resonance imaging (MRI) of breast cancer provides valuable data on the disease state of patients. Biocompatible nanoprobes are expected to play a pivotal role in medical diagnosis in the future owing to their prominent advantages. The present study aimed to introduce a novel biocompatible nanoprobe based on lipoproteins for breast cancer cell imaging.Materials and Methods: In this study, a biocompatible nanoprobe based on high-density lipoprotein was synthesized successfully. Scanning electron microscopy (SEM), Fourier-transform infrared spectroscopy (FTIR), and dynamic light scattering (DLS) were used for material characterization, and cellular uptake and in-vitro and in-vivo imaging were investigated using the nanoprobe. Results: The nanoprobe could significantly reduce the relaxation time in the phantom and cancer cells with no toxicity in the studied cells. In addition, the nanoprobe demonstrated proper cellular uptake in the cancer cells. The in-vivo tumor images were obtained 30, 60, and 120 minutes after the injection of the nanoprobe (5.0 µmol/kg) via the tail vein, and the results indicated that the synthesized nanoprobe could be introduced as a potential MRI contrast agent. Conclusion: Future developments may allow the application of this nanoparticle to be used in pathological and physiological processes in preclinical models.

کلیدواژه ها

Breast Cancer, Contrast Agent, High-density Lipoprotein, Nanoprobe

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.